睡眠時無呼吸症候群検査装置の世界市場2016-2026

【英語タイトル】Sleep Apnea Diagnostic System Market: Transition of Sleep Testing Services from Diagnostic Testing to Integrated Care is a Key Future Trend: Global Industry Analysis & Opportunity Assessment, 2016-2026

Future Market Insightsが出版した調査資料(FMI703041)・商品コード:FMI703041
・発行会社(調査会社):Future Market Insights
・発行日:2016年12月13日
・ページ数:176
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,130,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、睡眠時無呼吸症候群検査装置の世界市場について調査・分析し、睡眠時無呼吸症候群検査装置の世界市場動向、睡眠時無呼吸症候群検査装置の世界市場規模、市場予測、セグメント別睡眠時無呼吸症候群検査装置市場分析、地域別市場規模(北米市場、南米市場、アジア市場、日本市場、ヨーロッパ市場など)、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Obstructive sleep apnea is a common form of sleep apnea disorder across the world
Sleep disorders are highly prevailing in majority of regions globally and is affecting the population health severely. Troublesome ill effects of the disorder are important cause for increase in rate of adoption for sleep apnea diagnostic systems. Sleep apnea is a chronic disorder that can be bifurcated in two different types- obstructive sleep apnea (OSA) and central sleep apnea. Among the two, obstructive sleep apnea is a common form of sleep apnea and around 3% – 4% of the population is affected.

In terms of revenue, the global sleep apnea diagnostic system market is projected to expand at a CAGR of 7.3% over the forecast period and is expected to be valued more than US$ 600 Mn by the end of 2026.

Obesity and rapidly rising aging population play a crucial role in the growth of the global sleep apnea diagnostic system market

Robust growth of wearable sleep apnea diagnostic devices is expected in the near future due to rise
in adoption of home sleep testing services. Rising prevalence of obesity and rapidly ageing population in developed countries plays a crucial role in supporting growth of the market of sleep apnea diagnostic systems market. Introduction of novel technologies such as wireless screening devices and cloud based recording system are driving growth of the sleep services market. This in turn is expected to create a favourable environment for the global sleep apnea diagnostic system market over the forecast period.

Polysomnography segment will be able to achieve moderate growth in the forecast period

Although actigraphy monitoring devices of product type segment is expected to be the fastest growing segment over the forecast period, in terms of revenue share, currently the polysomnography monitoring devices sub-segment of product type segment offers the highest contribution in the global sleep apnea diagnostic system market. Polysomnography devices segment holds the largest market opportunity, accounting for a market share of approximately 40%. However, the polysomnography segment is experiencing moderate growth due to its nature and availability as an ambulatory testing device in future.

High obesity rate makes North America’s sleep apnea diagnostic market more lucrative than other regional markets

In terms of value, North America is expected to be the dominant regional market by 2016 end, and is expected to expand at a CAGR of 7.4% over the forecast period. Western Europe is expected to be the fastest growing market in terms of revenue growth in the global sleep apnea diagnostic system market, registering a CAGR of 7.5% during the forecast period. Adoption of sleep services is higher in North America due to high obesity rates and prevalent haphazard lifestyles. Also, new device development and their easy regulatory approval makes the North America sleep apnea diagnostic system market more lucrative as compared to other regional markets.

Company share analysis of the global sleep apnea diagnostic system market

Global sleep apnea diagnostic system market is consolidated and the introduction of novel technologies such as wireless screening devices and cloud based recording systems are driving growth of the global sleep services market. This in turn is expected to create a favourable environment for the global sleep apnea diagnostic system market over the forecast period. In 2015, Koninklijke Philips N.V., ResMed Inc., Becton, Dickinson and Company, Natus Medical Incorporated, MGC Diagnostics Corporation were the top five players dominating the global sleep apnea diagnostic system market contributing to around 83% of the total market share of sleep apnea diagnostic systems. In 2015, Koninklijke Philips N.V. dominated the market with around 38% market share of the global sleep apnea diagnostic system market followed by ResMED Inc. Koninklijke Philips N.V. has a strong foothold in the domestic market of North America, particularly in the rapidly growing respiratory and sleep disorder devices market.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Introduction

2.1. Taxonomy

2.2. Parent Market Analysis

3. Market Analysis Scenario

3.1. Pricing Analysis

3.1.1. Pricing Assumptions

3.1.2. Price Projections

3.2. Market Size and Forecast

3.2.1. Market Size and Y-o-Y Growth

3.2.2. Absolute $ Opportunity

3.3. Market Overview

4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunity

4.4. Forecast Factors – Relevance and Impact

4.5. Sleep Apnea Diagnosis Global Clinical Trials Review

4.6. Trends in Sleep Testing Services

5. Global Sleep Apnea Diagnostic System Market Analysis, 2016-2024

5.1. Introduction

5.1.1. Y-o-Y Growth Projection

5.1.2. Absolute $ Opportunity

6. Global Sleep Apnea Diagnostic System Market Analysis, By Product Type

6.1. Introduction

6.1.1. Global Sleep Apnea Diagnostic System Market Value Share, by Product Type

6.1.2. Y-o-Y Growth Comparison, By Product Type

6.2. Market Value Forecast, By Product Type

6.2.1. Polysomnography (PSG) Devices

6.2.1.1. Ambulatory PSG Monitoring Devices

6.2.1.2. Clinical PSG Monitoring Devices

6.2.2. Sleep Apnea Screening Devices

6.2.2.1. Nasal Flow Sensors

6.2.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

6.2.3. Actigraphy Monitoring Devices

6.3. Global Sleep Apnea Diagnostic System Market Attractiveness Analysis, by Product Type

6.4. Restraint Impact Analysis

7. Global Sleep Apnea Diagnostic System Market Analysis, By End User

7.1. Introduction

7.1.1. Global Sleep Apnea Diagnostic System Market Value Share, by End User

7.1.2. Y-o-Y Growth Comparison, By End User

7.2. Market Value and Volume Forecast, By End User

7.2.1. Home Care Settings

7.2.2. Hospitals

7.2.3. Sleep Centers and Clinics

7.3. Global Sleep Apnea Diagnostic System Market Attractiveness Analysis, by End User

7.4. Restraint Impact Analysis

8. Global Sleep Apnea Diagnostic System Market Analysis, By Region

8.1. Introduction

8.1.1. Global Sleep Apnea Diagnostic System Market Value Share, by Region

8.1.2. Global Sleep Apnea Diagnostic System Market Attractiveness By Region

8.2. Market Value and Volume Forecast, By Region

8.2.1. North America

8.2.2. Latin America

8.2.3. Western Europe

8.2.4. Eastern Europe

8.2.5. APEJ

8.2.6. Japan

8.2.7. MEA

8.3. Global Sleep Apnea Diagnostic System Market Attractiveness Analysis

9. North America Sleep Apnea Diagnostic System Market Analysis

9.1. Introduction

9.1.1. North America Sleep Apnea Diagnostic System Market Basis Point Share (BPS) Analysis, By Country

9.1.2. North America Sleep Apnea Diagnostic System Market Y-o-Y Growth Projections, By Country

9.1.3. North America Sleep Apnea Diagnostic System Market Value Forecast, By Country

9.1.4. Key Regulations

9.1.5. Prominent Trends

9.1.6. Market Attractiveness

9.1.7. Impact Analysis

9.2. Market Value and Volume Forecast

9.2.1. By Product Type

9.2.1.1. Polysomnography (PSG) Devices

9.2.1.1.1. Ambulatory PSG Monitoring Devices

9.2.1.1.2. Clinical PSG Monitoring Devices

9.2.1.2. Sleep Apnea Screening Devices

9.2.1.2.1. Nasal Flow Sensors

9.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

9.2.1.3. Actigraphy Monitoring Devices

9.2.2. By End User

9.2.2.1. Home Care Settings

9.2.2.2. Hospitals

9.2.2.3. Sleep Centers and Clinics

9.3. Restraints Impact Analysis

9.4. North America Sleep Apnea Diagnostic System Market Trends

9.5. North America Sleep Apnea Diagnostic System Market Attractiveness Analysis

10. Latin America Sleep Apnea Diagnostic System Market Analysis

10.1. Introduction

10.1.1. Latin America Sleep Apnea Diagnostic System Market Basis Point Share (BPS) Analysis, By Country

10.1.2. Latin America Sleep Apnea Diagnostic System Market Y-o-Y Growth Projections, By Country

10.1.3. Latin America Sleep Apnea Diagnostic System Market Value Forecast, By Country

10.1.4. Key Regulations

10.1.5. Prominent Trends

10.1.6. Market Attractiveness

10.1.7. Impact Analysis

10.2. Market Value and Volume Forecast

10.2.1. By Product Type

10.2.1.1. Polysomnography (PSG) Devices

10.2.1.1.1. Ambulatory PSG Monitoring Devices

10.2.1.1.2. Clinical PSG Monitoring Devices

10.2.1.2. Sleep Apnea Screening Devices

10.2.1.2.1. Nasal Flow Sensors

10.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

10.2.1.3. Actigraphy Monitoring Devices

10.2.2. By End User

10.2.2.1. Home Care Settings

10.2.2.2. Hospitals

10.2.2.3. Sleep Centers and Clinics

10.3. Restraints Impact Analysis

10.4. Latin America Sleep Apnea Diagnostic System Market Trends

10.5. Latin America Sleep Apnea Diagnostic System Market Attractiveness Analysis

11. Western Europe Sleep Apnea Diagnostic System Market Analysis

11.1. Introduction

11.1.1. Western Europe Sleep Apnea Diagnostic System Market Basis Point Share (BPS) Analysis, By Country

11.1.2. Western Europe Sleep Apnea Diagnostic System Market Y-o-Y Growth Projections, By Country

11.1.3. Western Europe Sleep Apnea Diagnostic System Market Value Forecast, By Country

11.1.4. Key Regulations

11.1.5. Prominent Trends

11.1.6. Market Attractiveness

11.1.7. Impact Analysis

11.2. Market Value and Volume Forecast

11.2.1. By Product Type

11.2.1.1. Polysomnography (PSG) Devices

11.2.1.1.1. Ambulatory PSG Monitoring Devices

11.2.1.1.2. Clinical PSG Monitoring Devices

11.2.1.2. Sleep Apnea Screening Devices

11.2.1.2.1. Nasal Flow Sensors

11.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

11.2.1.3. Actigraphy Monitoring Devices

11.2.2. By End User

11.2.2.1. Home Care Settings

11.2.2.2. Hospitals

11.2.2.3. Sleep Centers and Clinics

11.3. Restraints Impact Analysis

11.4. Western Europe Sleep Apnea Diagnostic System Market Trends

11.5. Western Europe Sleep Apnea Diagnostic System Market Attractiveness Analysis

12. Eastern Europe Sleep Apnea Diagnostic System Market Analysis

12.1. Introduction

12.1.1. Eastern Europe Sleep Apnea Diagnostic System Market Basis Point Share (BPS) Analysis, By Country

12.1.2. Eastern Europe Sleep Apnea Diagnostic System Market Y-o-Y Growth Projections, By Country

12.1.3. Eastern Europe Sleep Apnea Diagnostic System Market Value Forecast, By Country

12.1.4. Key Regulations

12.1.5. Prominent Trends

12.1.6. Market Attractiveness

12.1.7. Impact Analysis

12.2. Market Value and Volume Forecast

12.2.1. By Product Type

12.2.1.1. Polysomnography (PSG) Devices

12.2.1.1.1. Ambulatory PSG Monitoring Devices

12.2.1.1.2. Clinical PSG Monitoring Devices

12.2.1.2. Sleep Apnea Screening Devices

12.2.1.2.1. Nasal Flow Sensors

12.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

12.2.1.3. Actigraphy Monitoring Devices

12.2.2. By End User

12.2.2.1. Home Care Settings

12.2.2.2. Hospitals

12.2.2.3. Sleep Centers and Clinics

12.3. Restraints Impact Analysis

12.4. Eastern Europe Sleep Apnea Diagnostic System Market Trends

12.5. Eastern Europe Sleep Apnea Diagnostic System Market Attractiveness Analysis

13. APEJ Sleep Apnea Diagnostic System Market Analysis

13.1. Introduction

13.1.1. APEJ Sleep Apnea Diagnostic System Market Basis Point Share (BPS) Analysis, By Country

13.1.2. APEJ Sleep Apnea Diagnostic System Market Y-o-Y Growth Projections, By Country

13.1.3. APEJ Sleep Apnea Diagnostic System Market Value Forecast, By Country

13.1.4. Key Regulations

13.1.5. Prominent Trends

13.1.6. Market Attractiveness

13.1.7. Impact Analysis

13.2. Market Value and Volume Forecast

13.2.1. By Product Type

13.2.1.1. Polysomnography (PSG) Devices

13.2.1.1.1. Ambulatory PSG Monitoring Devices

13.2.1.1.2. Clinical PSG Monitoring Devices

13.2.1.2. Sleep Apnea Screening Devices

13.2.1.2.1. Nasal Flow Sensors

13.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

13.2.1.3. Actigraphy Monitoring Devices

13.2.2. By End User

13.2.2.1. Home Care Settings

13.2.2.2. Hospitals

13.2.2.3. Sleep Centers and Clinics

13.3. Restraints Impact Analysis

13.4. APEJ Sleep Apnea Diagnostic System Market Trends

13.5. APEJ Sleep Apnea Diagnostic System Market Attractiveness Analysis

14. Japan Sleep Apnea Diagnostic System Market Analysis

14.1. Introduction

14.1.1. Japan Sleep Apnea Diagnostic System Market Value Forecast

14.1.2. Key Regulations

14.1.3. Prominent Trends

14.1.4. Market Attractiveness

14.1.5. Impact Analysis

14.2. Market Value and Volume Forecast

14.2.1. By Product Type

14.2.1.1. Polysomnography (PSG) Devices

14.2.1.1.1. Ambulatory PSG Monitoring Devices

14.2.1.1.2. Clinical PSG Monitoring Devices

14.2.1.2. Sleep Apnea Screening Devices

14.2.1.2.1. Nasal Flow Sensors

14.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

14.2.1.3. Actigraphy Monitoring Devices

14.2.2. By End User

14.2.2.1. Home Care Settings

14.2.2.2. Hospitals

14.2.2.3. Sleep Centers and Clinics

14.3. Restraints Impact Analysis

14.4. Japan Sleep Apnea Diagnostic System Market Trends

14.5. Japan Sleep Apnea Diagnostic System Market Attractiveness Analysis

15. MEA Sleep Apnea Diagnostic System Market Analysis

15.1. Introduction

15.1.1. MEA Sleep Apnea Diagnostic System Market Basis Point Share (BPS) Analysis, By Country

15.1.2. MEA Sleep Apnea Diagnostic System Market Y-o-Y Growth Projections, By Country

15.1.3. MEA Sleep Apnea Diagnostic System Market Value Forecast, By Country

15.1.4. Key Regulations

15.1.5. Prominent Trends

15.1.6. Market Attractiveness

15.1.7. Impact Analysis

15.2. Market Value and Volume Forecast

15.2.1. By Product Type

15.2.1.1. Polysomnography (PSG) Devices

15.2.1.1.1. Ambulatory PSG Monitoring Devices

15.2.1.1.2. Clinical PSG Monitoring Devices

15.2.1.2. Sleep Apnea Screening Devices

15.2.1.2.1. Nasal Flow Sensors

15.2.1.2.2. Peripheral Capillary Oxygen Saturation (SPO2)

15.2.1.3. Actigraphy Monitoring Devices

15.2.2. By End User

15.2.2.1. Home Care Settings

15.2.2.2. Hospitals

15.2.2.3. Sleep Centers and Clinics

15.3. Restraints Impact Analysis

15.4. MEA Sleep Apnea Diagnostic System Market Trends

15.5. MEA Sleep Apnea Diagnostic System Market Attractiveness Analysis

16. Competitive Landscape

16.1. Competitive Dashboard

16.2. Company Share Analysis

16.3. Company Profile

16.3.1. Koninklijke Philips N.V.

16.3.2. SOMNOmedics GmbH

16.3.3. Advanced Brain Monitoring, Inc.

16.3.4. Braebon Medical Corporation

16.3.5. Becton, Dickinson and Company

16.3.6. MGC Diagnostics Corporation

16.3.7. Natus Medical Incorporated

16.3.8. Cleveland Medical Devices Inc.

16.3.9. BMC Medical Co, Ltd.

16.3.10. ResMed Inc.



【レポートのキーワード】

睡眠時無呼吸症候群検査装置、睡眠時無呼吸症候群診断

★調査レポート[睡眠時無呼吸症候群検査装置の世界市場2016-2026] (コード:FMI703041)販売に関する免責事項を必ずご確認ください。
★調査レポート[睡眠時無呼吸症候群検査装置の世界市場2016-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆